The Audited Finanacial Results (Standalone and Consolidated ) of the Company for Last Quarter and Year Ended March 31, 2025 and Audited Annual Accounts of the Company for the quarter and year ended 31st March, 2025
The Audited Financial Results (Standalone And Consolidated) Of The Company For The Last Quarter And Year Ended March 31, 2025 And Audited Annual Accounts Of The Company For The Quarter And Year Ended 31St March, 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Earlier from Supha Pharmachem
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Supha Pharmachem Ltd Press Release May 27 2025
- Board Meeting Intimation for Meeting Scheduled To Be Held On 30.05.2025.
- Supha Pharmachem Ltd Press Release May 22 2025
- Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended.
Later from Supha Pharmachem
- Board Meeting Outcome for The Audited Financial Results (Standalone And Consolidated) Of The Company For The Last Quarter And Year Ended March 31, 2025 And Audited Annual Accounts Of The Company The Quarter And Year Ended 31St March, 2025
- Appointment of Company Secretary and Compliance Officer
- Announcement under Regulation 30 (LODR)-Change in Management
- Supha Pharmachem Ltd Press Release May 30 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem